Forging Alliances with Industry

Virtually all of the professional master's degree (PMD) programs have consulted with industry along the way, and each academic institution maintains strong communication through retreats, conferences, and meetings. "We've been involving industry pretty heavily, not so much in developing curricula--we're doing that ourselves--but certainly in getting feedback from them on industry trends and jobs, and lining them up for internships for our students," says Keck Graduate Institute's David Gal

Written byA. J. S. Rayl
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Virtually all of the professional master's degree (PMD) programs have consulted with industry along the way, and each academic institution maintains strong communication through retreats, conferences, and meetings.

"We've been involving industry pretty heavily, not so much in developing curricula--we're doing that ourselves--but certainly in getting feedback from them on industry trends and jobs, and lining them up for internships for our students," says Keck Graduate Institute's David Galas. "We have maybe 25 companies that have been representative members of our corporate roundtable for the last six to nine months." Those companies include Allergan, Amgen, Baxter, Beckman Coulter, DuPont, Genentech, Monsanto, and SmithKline Beecham. "With the information revolution, the demand side is changing very fast, and that industry input is important," says Jesse H. Ausubel of Rockefeller University and the Sloan Foundation.

At Michigan State, says PMD project director Estelle McGroarty, "We talked with industrial advisers about what they see ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies